EC
GH icon

Elequin Capital’s Guardant Health GH Stock Holding History

Elequin Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-155
Closed -$14.3K – 787
2026
Q1 		$14.3K Sell
155
-208
-57% -$20.9K ﹤0.01% 292
2025
Q4 		$37.1K Buy
+363
New +$32.5K ﹤0.01% 154
2025
Q1 		– Sell
-9
Closed -$275 – 444
2024
Q4 		$275 Sell
9
-20
-69% -$563 ﹤0.01% 471
2024
Q3 		$665 Buy
+29
New +$821 ﹤0.01% 338
2024
Q2 		– Sell
-52
Closed -$1.07K – 250
2024
Q1 		$1.07K Buy
+52
New +$1.11K ﹤0.01% 198
2023
Q3 		– Sell
-138
Closed -$4.94K – 486
2023
Q2 		$4.94K Buy
+138
New +$3.96K ﹤0.01% 371
2023
Q1 		– Sell
-49
Closed -$1.33K – 405
2022
Q4 		$1.33K Sell
49
-121
-71% -$5.54K ﹤0.01% 590
2022
Q3 		$9K Sell
170
-165
-49% -$8.47K ﹤0.01% 274
2022
Q2 		$14K Buy
335
+20
+6% +$991 ﹤0.01% 211
2022
Q1 		$21K Buy
+315
New +$21.6K ﹤0.01% 116

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Elequin Capital's GH Position: Q2 2026 in Review

Elequin Capital sold out of Guardant Health (GH) in Q2 2026, closing a stake of 155 shares — an estimated $14.3K sold.

Elequin Capital first reported a position in GH in Q1 2022 and held it in 10 quarters. The position peaked at $37.1K in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Elequin Capital reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • Elequin Capital sold 155 Guardant Health shares in Q2 2026, an estimated $14.3K.
  • Elequin Capital first reported a position in Guardant Health in Q1 2022 and held it in 10 quarters.
  • Elequin Capital's Guardant Health position peaked at $37.1K in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.